Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesIncidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing
British Journal of Cancer, 09/12/06
N Pashayan, et al. - We investigated prostate cancer incidence in East Anglia from 1971to 2000. Using age-period-cohort modelling, the number of cases expected in 1991-2000, based on pre-PSA trends, 1971-1990, was compared with that observed. Based on pre-1991 trends, 9203 new cases were expected in 1991-2000, but 9788 cases were observed, an excess of 6%
Related Articles
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 92%%
Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years
Breast Cancer Research and Treatment, 11/13/09
Relevance Score: 90%%
Changing cancer incidence in Kampala, Uganda, 1991-2006
International Journal of Cancer, 11/10/09
Relevance Score: 90%%
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography
Cancer Causes and Control, 11/10/09
Relevance Score: 90%%
Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England
BJU International, 11/02/09
Relevance Score: 90%%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09
Article Search
Sponsor